Arkolith/Insider Trading/EFTR/Form 4

Worland Stephen T

Chief Executive Officer, DirectoreFFECTOR Therapeutics, Inc. (EFTR) · full profile →Form 4 · filed May 16, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2023Grant(A)6K$0.46$3K227K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-029646) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML